Loading...
•
Jun 30, 2024
Sanara MedTech Q2 2024 Earnings Report
Sanara MedTech reported eleventh consecutive record revenue quarter, driven by strong sales in the surgical team and supported by all functional areas, while also strengthening the senior management team.
Key Takeaways
Sanara MedTech reported a record revenue quarter with a 28% increase compared to the previous year, driven by increased sales of soft tissue repair products and market penetration. However, the company experienced a net loss due to increased SG&A costs, executive separation costs, acquisition costs, and higher amortization expenses.
Generated net revenue of $20.2 million, a 28% increase from the prior year period.
The number of facilities where products were sold grew to 800+ compared to 600+ in the same quarter last year.
Reported a net loss of $3.5 million, compared to a net loss of $1.9 million for the prior year quarter.
Generated Adjusted EBITDA of $0.6 million, compared to Adjusted EBITDA of ($0.3) million for the prior year quarter.
Revenue by Segment
Forward Guidance
No specific forward guidance was provided in the press release.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...